Beat AML S8 Group 2: Gilteritinib (GILT) in Combination with Decitabine (DEC) and Venetoclax (VEN) in Untreated FLT3 Mutated Acute Myeloid Leukemia (AML) Patients Age 60 with High and Low Variant Allele Frequency (VAF) Qiuying (Selina) Liu, Rina Li Welkie, Ying Huang,Ronan T. Swords,Tara L. Lin,Kristin L. Koenig,Yazan F. Madanat,Prapti A. Patel,Robert H. Collins,William Blum,Martha Arellano,Maria R. Baer,Wendy Stock,Tibor J. Kovacsovics,Rebecca Olin,Emily K. Curran,Eytan M. Stein,Gary J. Schiller,Joshua F. Zeidner,Robert L. Redner, Nyla A. Heerema, Molly Martycz, Leonard Rosenberg, Sonja Gullen Marcus, Timothy Chen, Mona Stefanos, Ross L. Levine, Brian J. Druker, Ashley Owen Yocum, Amy Burd, Alice Mims, Uma M. Borate, John C. Byrd, Elie TraerBLOOD（2023）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
